Driehaus Capital Management LLC 10x Genomics, Inc. Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$126.47 - $163.7 $6.97 Million - $9.02 Million	-55,115 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $183,624 - $262,500	2,100 Added 3.96%	55,115 $6.87 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $845,370 - $1.29 Million	14,478 Added 37.57%	53,015 $4.74 Million
Q1 2020 May 15, 2020	BUY	$51.57 - $106.62 $171,470 - $354,511	3,325 Added 9.44%	38,537 $2.4 Million
Q4 2019 Feb 12, 2020	BUY	$46.07 - $79.54 $1.14 Million - $1.97 Million	24,745 Added 236.41%	35,212 $2.69 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $523,245 - $648,954	10,467 New	10,467 $528,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.